For instance, reduced CYP46A1 activity has been linked to amyloid-beta accumulation and cognitive decline in AD, while altered CYP2D6 expression in the basal ganglia correlates with increased susceptibility to PD. This evidence concerns the gene CYP2D6 and Alzheimer disease.